TeraImmune Presented Research on TREGable™ Technology at
GERMANTOWN, Md., Nov. 18, 2022 (GLOBE NEWSWIRE) — TeraImmune, Inc., a biotechnology company focused on the discovery and development of novel Treg-based cell therapies for autoimmune diseases, announced today that…